USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
21.82
+0.15 (0.69%)
Feb 23, 2026, 4:00 PM EST - Market closed
USANA Health Sciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for USANA Health Sciences stock has a target of 36, which predicts a 64.99% increase from the current stock price of 21.82.
Price Target: $36 (+64.99%)
Analyst Consensus: Hold
* Price targets were last updated on Feb 27, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for USANA Health Sciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Hold Maintains $38 → $36 | Hold | Maintains | $38 → $36 | +64.99% | Feb 27, 2025 |
| DA Davidson | DA Davidson | Hold Maintains $35 → $38 | Hold | Maintains | $35 → $38 | +74.15% | Jan 2, 2025 |
| DA Davidson | DA Davidson | Hold Maintains $38 → $35 | Hold | Maintains | $38 → $35 | +60.40% | Oct 23, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $46 → $38 | Hold | Maintains | $46 → $38 | +74.15% | Jul 25, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $48 → $46 | Hold | Maintains | $48 → $46 | +110.82% | May 7, 2024 |
Financial Forecast
Revenue This Year
975.30M
from 925.26M
Increased by 5.41%
Revenue Next Year
1.04B
from 975.30M
Increased by 6.12%
EPS This Year
1.99
from 0.58
Increased by 243.34%
EPS Next Year
2.87
from 1.99
Increased by 44.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.0B | 1.1B |
| Avg | 975.3M | 1.0B |
| Low | 937.1M | 994.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 8.5% | 9.3% |
| Avg | 5.4% | 6.1% |
| Low | 1.3% | 2.0% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 2.05 | 2.95 |
| Avg | 1.99 | 2.87 |
| Low | 1.91 | 2.75 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 253.4% | 48.3% |
| Avg | 243.3% | 44.1% |
| Low | 229.9% | 38.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.